From Beaker to Tonnage: What Silent Revolution Is the Core Engine of Biomanufacturing Undergoing?

From shake-flask fermentation in the lab to intelligent operations in million-ton production facilities; from large-scale supply of antibiotics and amino acids to breakthroughs in biodegradable plastics and bio-feed.Fermentation is the critical step that enables biomanufacturing to move from "0" to "1".

It goes beyond traditional "brewing" or "antibiotic production." It is the essential pathway to scaling up bio-based products—from alternative proteins and biomaterials to pharmaceutical intermediates and functional ingredients.

[Industrial Fermentation]

Industrial fermentation is the process of converting substrates into target products using microbial metabolic activity under controlled conditions.

But at a more fundamental level, fermentation is humanity's "collective domestication" of microorganisms.

Traditional fermentation (brewing, vinegar-making, and soy sauce production) relied on humans' unintentional use of microbes' natural metabolic capabilities. In contrast, modern industrial fermentation is a systematic engineering process that purposefully engineers microorganisms, precisely controls environmental conditions, and efficiently harvests products.

In the biomanufacturing value chain, fermentation processes occupy a pivotal role that bridges upstream and downstream operations.: Upward, it determines whether the gene-edited strain can scale from plate culture to bioreactor; downward, it dictates product concentration and impurity profiles in the fermentation broth, directly impacting purification costs and final product quality.

[ Pain Point: The "Valley of Death" When Scaling Up ]

The ultimate goal of scale-up is to precisely translate optimal operating conditions from laboratory or pilot-scale bioreactors into an efficient production mode for full-scale bioreactors, maximizing volumetric productivity across all scales.

If laboratory-scale fermentation (1L-10L) is an art, industrial-scale fermentation (10 tons-500 tons) is a war.Many promising lab strains and datasets fail when scaled up to pilot or production levels.

Challenge 1: Non-uniformity in Mixing and Mass Transfer

In shake flasks or small bioreactors in the lab, the culture medium is considered "well-mixed," so each microbe experiences nearly identical conditions. However,In hundred-ton-scale bioreactors, significant pressure differences exist between the tank bottom and top, shear forces vary greatly near the impeller versus the tank wall, substrate concentrations differ markedly between feed points and distant regions, and dissolved oxygen gradients form along the bubble rise path.and other factors.

These factors mean microbes inside the tank do not live in a uniform environment but in distinct "micro-niches." This can lead to metabolic heterogeneity, affecting overall yield.

Challenge 2: The Limit of Oxygen Transfer Rate

For aerobic fermentation (which encompasses the vast majority of industrial processes), oxygen is often the most limiting substrate. The oxygen transfer rate depends on factors such as gas-liquid interfacial area, the oxygen mass transfer coefficient, and the partial pressure difference of oxygen across the gas-liquid interface.

In large tanks, oxygen supply is often more challenging than in small tanks due to increased hydrostatic pressure and longer mixing times.The potential of many strains is also limited by hypoxia.

Challenge 3: Exponential increase in contamination risk

The larger the fermentation scale, the more complex the sterile barrier becomes (with additional valves, ports, and sensor connections), the longer the operation time extends (including post-sterilization cooling delays), and the higher the risk of contamination.A single contamination incident can disrupt an entire week's production schedule.

[ Breakthroughs: Which Technologies Are Actually Landing? ]

From "black-box operations" to "transparent processes"

In traditional fermentation processes, operators can only monitor a limited set of parameters (temperature, pH, and agitation speed), leaving them unable to track real-time substrate levels, product accumulation, or the presence of inhibitory byproducts in the bioreactor.

New Process Analytical Technology (PAT)Transforming the landscape: Raman spectroscopy enables in-situ monitoring of key metrics such as glucose, lactate, acetate, ethanol, and target products; near-infrared spectroscopy rapidly measures cell density and substrate concentration.

With this data, operators can "see" in real time what is happening inside the tank and adjust feeding strategies, agitation speed, temperature, and other parameters accordingly.

From manual expertise to AI-assisted decision-making

Leveraging machine learning and fermentation big data, we can analyze exhaust gas composition and pH change rates to issue early contamination alerts (even 2–4 hours before visible signs); based on real-time substrate concentration data.AIThe algorithm dynamically calculates the optimal flow rate to maintain substrate concentration within an ideal range. By leveraging historical batch data, it predicts the final yield for the current batch and determines the optimal time for tank discharge.

From Batch Production to Continuous Manufacturing

Traditional fermentation is batch-based: feeding, sterilization, inoculation, fermentation, discharge, and cleaning. This cycle repeats with significant non-production time between batches.

ApprovedContinuous Fermentation and Online Separation TechnologyAchieve 7×24 hours of continuous production, significantly improving equipment utilization, product concentration stability, and volumetric productivity. While this approach demands extremely high standards for strain stability and aseptic assurance, its application scope is gradually expanding.

From Single Reactor to Digital Twin Factory

Digital TwinA virtual fermentation system that syncs in real-time with the physical system, simulating trends for the next few hours based on current conditions. It identifies the root cause and location of issues when batch results are abnormal, and allows testing of new parameters and strategies in a virtual environment before deploying them to the live system.

These fermentation technologies are being deployed, progressively advancing biomanufacturing from the lab to industrial and intelligent scales. To experience these applications firsthand and explore future directions with industry peers, 2026 Echemi Biomanufacturing Industry Exhibition is an opportunity you shouldn't miss.

The 2026 BIO-TECH Manufacturing Industry Expo will be held grandly in Shanghai from 8/27-28.This exhibition is organized by Yimao Medical. Invited guests will be present on-site, including:2000+Attendee,150+ Speaker,50+Premium exhibitors, featuring "Exhibitions - Products - Conferences - PartnershipsFour core modules focused on "breakthroughs in fundamental research and cross-sector industrialization," establishing a benchmark event for the entire bio-manufacturing value chain.